<DOC>
	<DOC>NCT02784457</DOC>
	<brief_summary>Efficacy of the use of GnRH antagonist in treatment of those who develop early-onset severe ovarian hyperstimulation syndrome and had cancelled embryo transfer</brief_summary>
	<brief_title>Gonadotropin Releasing Hormone Antagonist in Treatment of Early-onset Severe Ovarian Hyperstimulation Syndrome</brief_title>
	<detailed_description />
	<mesh_term>Ovarian Hyperstimulation Syndrome</mesh_term>
	<mesh_term>Hormones</mesh_term>
	<mesh_term>Hormone Antagonists</mesh_term>
	<mesh_term>Cetrorelix</mesh_term>
	<criteria>Women who develop earlyonset severe ovarian hyperstimulation syndrome after controlled ovarian stimulation using long GnRH agonist protocol and hCG for triggering ovulation. Women on short or antagonist protocols. Women who received GnRH agonist for triggering ovulation. Women who had embryo transfer.</criteria>
	<gender>Female</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>42 Years</maximum_age>
	<verification_date>May 2016</verification_date>
</DOC>